Winnergy Medical Public Company Limited (WINMED), in collaboration with Docquity, the Thai Gynecologic Cancer Society (TGCS), and the Faculty of Medicine Vajira Hospital, recently co-hosted the academic seminar “AI Summit: Shaping the Future of Care” to promote the integration of artificial intelligence into modern medical practice.

The event featured a special presentation by Dr. Pariwat Pawanna from Thammasat University Hospital, a new-generation physician with a strong interest in AI applications in clinical settings. Dr. Pariwat presented his research titled “Role of AI for Predicting Precancerous Lesion of Cervix,” which explores the use of deep learning to analyze cervical images for early detection of precancerous changes.

A highlight of the event was the introduction of CerviCARE® AI, a smart colposcope with integrated AI technology developed by WINMED. This device was evaluated in a comparative study against expert colposcopist assessments and cytology (Pap smear) results. Key features of CerviCARE® AI include:

✅ AI-based cervical cancer screening

✅ Rapid analysis within 5 seconds

✅ High diagnostic sensitivity

✅ Powered by a database of over 7 million clinical cases

✅ Certified by major international standards: U.S. FDA, K.FDA, and CE Mark

WINMED remains committed to advancing high-quality, safe, and innovative medical technologies to support Thailand’s public health system. By enhancing early screening capabilities, especially for cervical cancer, the company aims to reduce preventable mortality and improve healthcare outcomes for Thai women nationwide.